Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone with Concurrent Chemoradiotherapy for Unresectable Thymoma
NCT06730308Phase 2Recruiting
- Sponsor
- Sun Yat-sen University
- Start
- Nov 2024
- Primary completion
- Nov 2028
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of methylprednisolone in thymoma, sponsored by Sun Yat-sen University. Started Nov 2024; status: recruiting.
02
Drugs
methylprednisolone
03
Conditions
thymoma
Beyond the preview
Go deeper on NCT06730308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06730308.